                         SEQUENCE LISTING

<110>  TAKEDA PHARMACEUTICAL COMPANY LIMITED

<120>  PREVENTION AND TREATMENT OF CANCER WITH LKB1 NON-EXPRESSION (DELETION OR MUTATION)

<130>  20213.0003WOU1

<140>  New Filing 
<141>  

<150>  US61/100603
<151>  2008-09-26

<160>  4     

<170>  PatentIn version 3.1

<210>  1
<211>  66
<212>  DNA
<213>  Artificial

<220>
<223>  primer for cloning human HER2 gene

<400>  1
aattaagtcg acatggacta caaagacgat gacgacaagc gacggcagca gaagatccgg     60

aagtac                                                                66

<210>  2
<211>  42
<212>  DNA
<213>  Artificial

<220>
<223>  primer for cloning human HER2 gene

<400>  2
aattaagcat gctcacactg gcacgtccag acccaggtac tc                        42

<210>  3
<211>  66
<212>  DNA
<213>  Artificial

<220>
<223>  primer for cloning human EGFR gene

<400>  3
aattaagtcg acatggacta caaagacgat gacgaccgaa ggcgccacat cgttcggaag     60

cgcacg                                                                66

<210>  4
<211>  42
<212>  DNA
<213>  Artificial

<220>
<223>  primer for cloning human EGFR gene

<400>  4
aattaagcat gctcatgctc caataaattc actgctttgt gg                        42
